about
Biotin IgM antibodies in human blood: a previously unknown factor eliciting false results in biotinylation-based immunoassaysT-helper cell-mediated proliferation and cytokine responses against recombinant Merkel cell polyomavirus-like particles.Erythroid progenitor cells expanded from peripheral blood without mobilization or preselection: molecular characteristics and functional competence.Clinical assessment and improved diagnosis of bocavirus-induced wheezing in children, Finland.Novel human bufavirus genotype 3 in children with severe diarrhea, Bhutan.Human circovirus TT virus genotype 6 expresses six proteins following transfection of a full-length cloneMultiplex detection in tonsillar tissue of all known human polyomaviruses.Newly discovered KI, WU, and Merkel cell polyomaviruses: no evidence of mother-to-fetus transmissionLife-threatening respiratory tract disease with human bocavirus-1 infection in a 4-year-old child.Association of human bocavirus 1 infection with respiratory disease in childhood follow-up study, Finland.Establishment of a reverse genetics system for studying human bocavirus in human airway epitheliaAcute parvovirus B19 infection causes nonspecificity frequently in Borrelia and less often in Salmonella and Campylobacter serology, posing a problem in diagnosis of infectious arthropathy.Real-time quantitative PCR detection of four human bocaviruses.Merkel cell polyomavirus and trichodysplasia spinulosa-associated polyomavirus DNAs and antibodies in blood among the elderly.Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissuePersistence of human parvovirus B19 in human tissues.VP1u phospholipase activity is critical for infectivity of full-length parvovirus B19 genomic clonesSerodiagnosis of primary infections with human parvovirus 4, Finland.B-Cell Responses to Human Bocaviruses 1-4: New Insights from a Childhood Follow-Up StudySevere human bocavirus infection, Germany.Microsphere-based antibody assays for human parvovirus B19V, CMV and T. gondii.Rapid sequence change and geographical spread of human parvovirus B19: comparison of B19 virus evolution in acute and persistent infectionsMapping Antigenic Epitopes on the Human Bocavirus Capsid.Primary and secondary human bocavirus 1 infections in a family, Finland.Human bocavirus in patients with encephalitis, Sri Lanka, 2009-2010.Epidemiology of two human protoparvoviruses, bufavirus and tusavirus.Identification of past and recent parvovirus B19 infection in immunocompetent individuals by quantitative PCR and enzyme immunoassays: a dual-laboratory study.Seroepidemiology of human bocaviruses 1-4.New respiratory viruses and the elderly.Human bocavirus-the first 5 years.New respiratory viral infections.Human bocavirus infections.New molecular virus detection methods and their clinical value in lower respiratory tract infections in children.Diagnostic methods for and clinical pictures of polyomavirus primary infections in children, Finland.Structural Insights into Human Bocaparvoviruses.Human Parvoviruses.Human bocavirus infection diagnosed serologically among children admitted to hospital with community-acquired pneumonia in a tropical region.Genomic features of the human bocavirusesExpression and serological characterization of polyomavirus WUPyV and KIPyV structural proteins.Polyomaviruses BK, JC, KI, WU, MC, and TS in children with allogeneic hematopoietic stem cell transplantation.
P50
Q28482074-6F742E91-1EB0-4945-B5D9-94900013A5E2Q31032531-D7E4CA02-6A54-4968-A3C6-0F75AE58A707Q33538033-C1538071-17CC-4736-978E-7B7221455743Q33644784-857943F9-9D67-4D4E-BF84-27CA0EC7A3B8Q33678508-E6C2EB28-F2D9-4C7F-ABCA-A5774B31CB37Q33780484-4B9E2B89-5DB4-4E68-9E65-D998022864B1Q33781568-C531B926-0CC9-41D0-BA6D-5FF2637D64EEQ34203417-0EAD1F17-FD0A-4E72-9C89-C7FBFD2CEA24Q34237555-330881E5-21EE-4B80-A283-94FEB871F3C3Q34251955-116E2461-259A-40EB-86B4-45BFD0C8B025Q34407786-7200063B-6FF7-453B-938E-C5006457D452Q34484079-277D59D6-EC15-4357-A4FD-E375EF51BAF7Q34489573-8600ADF7-D757-4384-A964-5604310408ADQ34524022-45D817CD-EAF3-4B29-841A-93BA4E069DCAQ34624583-CC22A46F-8B6F-475B-92DD-9F61B1D078AFQ34737815-15B62719-38F9-4A2D-A84C-CB06506FC8C3Q34813312-0AD5D583-2F55-482C-AE00-2158684CE209Q35482591-F4F82935-4CE2-4799-A43F-9BAA942EC082Q35791624-5A2FDE7A-FE0B-4FEB-A53E-BB7DE96D4023Q35849004-F51F05BA-DEC4-48B1-BAD0-01280DC234D5Q35889013-4D72FBC2-1D32-469B-A93A-567D6F95ADF4Q36747943-70F938E3-5972-438B-9F0C-B573E05561A5Q36811975-C73E8518-9BC6-4EA4-BCA1-0839D4CD0EB4Q37085068-601D9559-02DE-4E6C-8F3C-DAD6616C116BQ37335130-F1604720-5606-4B87-84EF-A8AEF8122C18Q37501495-D036DB3D-CB3E-46D3-974C-8564D49DD381Q37643489-75434989-95BC-4737-BF7F-2993D2EC856DQ37705552-883801A0-FDFA-483E-988F-7898C466A8D0Q37901388-D6514BB9-EC95-4B63-B115-003227643E4AQ37950974-89061F0A-8FD8-41F2-99F1-2E67294A0C5BQ37988344-674FCD03-5259-4D27-864B-4748164C81C2Q38074814-ED8BF440-8B1A-4F62-91F3-28D47111E7E2Q38076552-EC401DBA-C4AC-44F6-A0E8-F0BF6047FC20Q38523881-A24BC921-A73D-4E10-9CEF-6AEA9F80741CQ38741334-96D5D1E7-3ED3-4538-9184-62A365D4604FQ38996997-1EA08C79-7460-461C-AD3F-A82E04354C5EQ39294438-C1F3331D-1515-4CB2-9C03-9F6EFE1B977FQ39644951-CAE9A812-2342-407C-90BD-4C3AFE7CB56BQ39667181-4E857799-913E-4F78-96F0-68170B0335D6Q39869601-D4C5CE11-7C05-445C-A856-4F02454DCD02
P50
description
onderzoeker
@nl
name
Maria Söderlund-Venermo
@ast
Maria Söderlund-Venermo
@en
Maria Söderlund-Venermo
@es
Maria Söderlund-Venermo
@sl
type
label
Maria Söderlund-Venermo
@ast
Maria Söderlund-Venermo
@en
Maria Söderlund-Venermo
@es
Maria Söderlund-Venermo
@sl
prefLabel
Maria Söderlund-Venermo
@ast
Maria Söderlund-Venermo
@en
Maria Söderlund-Venermo
@es
Maria Söderlund-Venermo
@sl